Bionano Genomics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2017 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bionano Genomics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2017 to Q2 2025.
  • Bionano Genomics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $1.08M, a 58.2% decline year-over-year.
  • Bionano Genomics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $6.81M, a 47.5% decline year-over-year.
  • Bionano Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $9.74M, a 35.9% decline from 2023.
  • Bionano Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $15.2M, a 32.3% decline from 2022.
  • Bionano Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $22.4M, a 131% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $6.81M $1.08M -$1.5M -58.2% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $8.31M $1.59M -$1.43M -47.4% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $9.74M $1.94M -$1.44M -42.6% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 $11.2M $2.2M -$1.79M -44.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $13M $2.58M -$1.35M -34.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $14.3M $3.02M -$867K -22.3% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q4 2023 $15.2M $3.37M -$2.11M -38.5% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 $17.3M $3.99M -$2.07M -34.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $19.4M $3.93M -$1.85M -31.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $21.2M $3.88M -$1.22M -23.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $22.4M $5.48M +$677K +14.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $21.7M $6.06M +$3.27M +117% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $18.5M $5.78M +$4.02M +229% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $14.5M $5.1M +$4.73M +1275% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $9.72M $4.8M +$4.35M +965% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $5.37M $2.79M +$2.34M +524% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $3.03M $1.76M +$1.43M +436% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.6M $371K +$43K +13.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.55M $451K +$94K +26.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $1.46M $447K +$83K +22.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1.38M $328K -$8K -2.38% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $1.39M $328K +$39K +13.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $1.35M $357K +$303K +556% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 $1.04M $364K +$311K +585% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $733K $336K +$283K +534% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $450K $289K Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-18
Q4 2018 $54.4K Oct 1, 2018 Dec 31, 2018 10-Q 2019-05-09
Q3 2018 $53.1K +$29K +120% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $53K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q3 2017 $24.1K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.